AI
LMAT icon

Atria Investments’s LeMaitre Vascular LMAT Stock Holding History

Atria Investments’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$831K Buy
7,612
+2,459
+48% +$234K 0.01% 1163
2025
Q4 		$418K Sell
5,153
-170
-3% -$14.6K ﹤0.01% 1551
2025
Q3 		$466K Sell
5,323
-1,095
-17% -$97.8K 0.01% 1455
2025
Q2 		$533K Sell
6,418
-85
-1% -$7.1K 0.01% 1384
2025
Q1 		$546K Sell
6,503
-1,985
-23% -$185K 0.01% 1309
2024
Q4 		$782K Sell
8,488
-365
-4% -$35.1K 0.01% 1113
2024
Q3 		$822K Buy
8,853
+2,701
+44% +$234K 0.01% 1079
2024
Q2 		$506K Buy
+6,152
New +$452K 0.01% 1294

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Atria Investments's LMAT Position: Q1 2026 in Review

Atria Investments increased its LeMaitre Vascular (LMAT) stake by 48% in Q1 2026, buying an estimated $234K and bringing the position to 7,612 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #1163.

Atria Investments first reported a position in LMAT in Q2 2024 and has held it in 8 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Atria Investments held 7,612 shares of LeMaitre Vascular worth $831K as of Q1 2026.
  • Atria Investments bought 2,459 LeMaitre Vascular shares in Q1 2026, an estimated $234K.
  • LeMaitre Vascular made up 0.01% of Atria Investments's portfolio in Q1 2026, its #1163 holding.
  • Atria Investments first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 8 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.